Rivian enters the final stretch before its October 27 earnings report with a familiar tension: short sellers are rebuilding positions into a stock that has dropped 11% over the past month to $15.14, while options traders have turned more defensive than at almost any point this year.
The clearest signal this week is in the options market. The put/call ratio has jumped to 0.976 — more than 2.4 standard deviations above its 20-day average of 0.92 — a defensive tilt this pronounced has not appeared often in the past 52 weeks, where the PCR range runs from 0.78 to 1.21. Traders are reaching for downside protection, and they are doing it now, five weeks before the print. That defensiveness is not matched by an aggressive short squeeze setup. Short interest runs at 13.4% of the free float — high by most definitions — and has climbed roughly 8% over the past month to around 163.7 million shares. The borrow market, however, is not tight. Availability is running at roughly 195%, meaning there are nearly two shares available to lend for every one already borrowed. Cost to borrow is a very relaxed 0.54%, essentially unchanged for weeks. Shorts are adding to positions, but they are doing so without paying a premium for the privilege — positioning looks meaningful rather than desperate.
The Street is similarly split rather than aligned. Citigroup initiated coverage last week with a Neutral rating and an $18 target, a level 19% above the current price but below the $19.31 consensus mean. Morgan Stanley, which has maintained an Underweight since at least mid-year, raised its target to $14 — the lone below-market call that stands out for sitting beneath where the stock trades today. Bulls at TD Cowen ($21 target, Buy) and Needham ($23, Buy) point to the Volkswagen joint venture, Amazon delivery contract, and the midsize SUV pipeline as reasons to look through near-term losses. Bears flag execution risk, ongoing cash burn, and negative EBITDA that still ran around -$472 million last quarter. Factor scores tilt toward the skeptics: the ORTEX short score sits at 68.4 — in the top quartile of bearish readings across the universe — and EPS momentum ranks in just the 10th to 12th percentile on both 30- and 90-day horizons, meaning estimate revisions have been moving the wrong way.
The institutional register offers its own subplot. Volkswagen AG filed an amended 13G in May disclosing a 15.9% stake — up from 12.3% previously — confirming the strategic relationship is deepening on paper even as the share price drifts lower. Porsche Automobil Holding SE holds a further 14.5% as of April, making Volkswagen-linked entities the dominant shareholders by a wide margin. The recent insider flow is less encouraging: the CFO and Chief Administrative Officer both sold shares in August and September under pre-arranged 10b5-1 plans, while the CEO's August activity was a tax-withholding transaction rather than a discretionary sale. None of this is alarming — 10b5-1 sales are mechanical — but there were no open-market purchases to offset them. Net insider activity over the past 90 days amounts to a modest -$963,000 in value across -56,167 shares.
Rivian's earnings history gives shorts a reason for confidence and bulls a reason to wince. The July 30 print produced a one-day drop of 6.8% and a further slide to -5.8% over the following five sessions. The prior quarter's release in late April was milder at -0.9% on the day, but still negative. Both of Rivian's closest US peers had a better week: TSLA gained 6.3% and LCID added 4.9%, widening the performance gap with RIVN's -2.6% weekly return. The stock is trading at a price-to-book of about 6.2x — elevated for a company still deeply unprofitable — and the EV/EBITDA multiple is negative, a reminder that the valuation case rests entirely on delivery volume growth rather than current earnings power.
What to watch between now and October 27 is whether Q3 deliveries — due before the earnings call — come in within or above the company's 62,000–67,000 unit annual guidance range, and whether any update on the midsize SUV production timeline shifts the analyst consensus off its current cautious-neutral stance.
See the live data behind this article on ORTEX.
Open RIVN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
